Wellcome Sanger Institute, Wellcome Genome Campus, Hinxton, Cambridgeshire, UK.
Department of Pathology and Pathogen Biology, Centre for Emerging, Endemic and Exotic Diseases, Royal Veterinary College, University of London, Herts, UK.
Nat Commun. 2021 Aug 6;12(1):4776. doi: 10.1038/s41467-021-24958-0.
Control and elimination of the parasitic disease schistosomiasis relies on mass administration of praziquantel. Whilst these programmes reduce infection prevalence and intensity, their impact on parasite transmission and evolution is poorly understood. Here we examine the genomic impact of repeated mass drug administration on Schistosoma mansoni populations with documented reduced praziquantel efficacy. We sequenced whole-genomes of 198 S. mansoni larvae from 34 Ugandan children from regions with contrasting praziquantel exposure. Parasites infecting children from Lake Victoria, a transmission hotspot, form a diverse panmictic population. A single round of treatment did not reduce this diversity with no apparent population contraction caused by long-term praziquantel use. We find evidence of positive selection acting on members of gene families previously implicated in praziquantel action, but detect no high frequency functionally impactful variants. As efforts to eliminate schistosomiasis intensify, our study provides a foundation for genomic surveillance of this major human parasite.
控制和消除寄生虫病血吸虫病依赖于大规模使用吡喹酮。虽然这些项目降低了感染的流行率和强度,但它们对寄生虫传播和进化的影响还知之甚少。在这里,我们研究了重复大规模药物治疗对具有记录的吡喹酮疗效降低的曼氏血吸虫种群的基因组影响。我们对来自乌干达 34 名儿童的 198 个曼氏血吸虫幼虫进行了全基因组测序,这些儿童来自具有不同吡喹酮暴露的地区。感染来自维多利亚湖的儿童的寄生虫形成了一个多样化的混合种群。单次治疗并没有降低这种多样性,也没有因长期使用吡喹酮而导致明显的种群收缩。我们发现了证据表明,先前涉及吡喹酮作用的基因家族成员受到了正向选择,但没有检测到高频功能影响的变异。随着消除血吸虫病的努力的加强,我们的研究为这种主要的人类寄生虫的基因组监测提供了基础。